Void space and long-term volumetric changes of maxillary sinus floor augmentation with comparison between hydroxyapatite soaked with bone morphogenetic protein 2 and anorganic bovine xenograft alone

J Craniomaxillofac Surg. 2019 Oct;47(10):1626-1632. doi: 10.1016/j.jcms.2019.07.016. Epub 2019 Jul 19.

Abstract

Purpose: We hypothesized that the void volume after maxillary sinus floor augmentation (MSFA) with recombinant human bone morphogenetic protein-2 (rhBMP-2) would be larger than that without rhBMP-2, and filled with bone in the long term. The aim of this study was to analyze the occurrence of void space and long-term volumetric changes after MSFA with rhBMP-2 and hydroxyapatite (BMP-2/H).

Material and methods: In 25 subjects, MSFA was performed with BMP-2/H (group I) or an anorganic bovine xenograft (group II). Computed tomography scans were taken twice, at 3 months (T1) and at least 24 months (T2) after surgery. Total volume (TV), bone volume (BV), and void volume (VV) were measured and analysed statistically.

Results: While similar amounts of graft material were used, the TV was significantly larger in group I than in group II (p = 0.014). The VV showed a tendency to be larger in group I than in group II. VV reduction up to T2 was significantly greater in group I than in group II. Consequently, the BV at T2 was significantly greater in group I than in group II by 36% (p = 0.014).

Conclusion: This study showed that our hypothesis was valid. rhBMP-2 is effective for long-term bone regeneration after MSFA.

Keywords: Bone regeneration; Computed tomography; Maxillary sinus floor augmentation; Recombinant human bone morphogenetic protein 2; Void.

MeSH terms

  • Animals
  • Bone Morphogenetic Protein 2
  • Bone Transplantation
  • Cattle
  • Durapatite
  • Heterografts
  • Humans
  • Maxillary Sinus
  • Sinus Floor Augmentation*

Substances

  • Bone Morphogenetic Protein 2
  • Durapatite